These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33130088)

  • 1. Identification and characterization of a rare variant in apolipoprotein A-IV, p.(V336M), and evaluation of HDL functionality in a Greek cohort with extreme HDL cholesterol levels.
    Chroni A; Rallidis L; Vassou D; Gkolfinopoulou C; Papakosta P; Zervou MI; Goulielmos GN; Kiouri E; Pappa D; Eliopoulos E; Kardassis D
    Arch Biochem Biophys; 2020 Dec; 696():108655. PubMed ID: 33130088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
    Göçmen AY; Gümüşlü S; Semiz E
    Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease.
    Hancock-Cerutti W; Millar JS; Valentini S; Liu J; Billheimer JT; Rader DJ; Cuchel M
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial apolipoprotein A-I and C-III deficiency, variant II.
    Schaefer EJ; Ordovas JM; Law SW; Ghiselli G; Kashyap ML; Srivastava LS; Heaton WH; Albers JJ; Connor WE; Lindgren FT
    J Lipid Res; 1985 Sep; 26(9):1089-101. PubMed ID: 3934306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional basis for increased HDL-cholesterol levels due to the naturally occurring V19L mutation in human apolipoprotein A-I.
    Gkolfinopoulou C; Bourtsala A; Chroni A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Mar; 1865(3):158593. PubMed ID: 31863971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of endothelial lipase gene related single nucleotide polymorphisms in patients with coronary artery disease.
    Abudureyimu S; Abulaiti P; Li H; Xing Z; Liu S; Li W; Gao Y
    Gene; 2021 Jul; 788():145669. PubMed ID: 33882321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic basis of dyslipidemia in disease precipitation of coronary artery disease (CAD) associated type 2 diabetes mellitus (T2DM).
    Raj R; Bhatti JS; Badada SK; Ramteke PW
    Diabetes Metab Res Rev; 2015 Oct; 31(7):663-71. PubMed ID: 25470794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A-IV levels and phenotype distribution in NIDDM.
    Vergès BL; Vaillant G; Goux A; Lagrost L; Brun JM; Gambert P
    Diabetes Care; 1994 Aug; 17(8):810-7. PubMed ID: 7956623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.
    Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M
    J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein A-IV polymorphism in Saami and Finns: frequency and effect on serum lipid levels.
    Lehtinen S; Luoma P; Näyhä S; Hassi J; Ehnholm C; Nikkari T; Peltonen N; Jokela H; Koivula T; Lehtimäki T
    Ann Med; 1998 Apr; 30(2):218-23. PubMed ID: 9667802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age, Sex, and Cardiovascular Risk Attributable to Lipoprotein Cholesterol Among Chinese Individuals with Coronary Artery Disease: A Case-Control Study.
    Wu TT; Zheng YY; Yang YN; Li XM; Ma YT; Xie X
    Metab Syndr Relat Disord; 2019 May; 17(4):223-231. PubMed ID: 30720383
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
    Gugliucci A
    Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population.
    Antiochos P; Marques-Vidal P; Virzi J; Pagano S; Satta N; Hartley O; Montecucco F; Mach F; Kutalik Z; Waeber G; Vollenweider P; Vuilleumier N
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2342-2349. PubMed ID: 29074586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice.
    Tiniakou I; Kanaki Z; Georgopoulos S; Chroni A; Van Eck M; Fotakis P; Zannis VI; Kardassis D
    Atherosclerosis; 2015 Nov; 243(1):77-85. PubMed ID: 26363436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease.
    Asztalos BF; Roheim PS; Milani RL; Lefevre M; McNamara JR; Horvath KV; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2670-6. PubMed ID: 11116070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease.
    Kallend DG; Reijers JA; Bellibas SE; Bobillier A; Kempen H; Burggraaf J; Moerland M; Wijngaard PL
    Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):23-9. PubMed ID: 27418968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of human apolipoprotein A-IV: a distinct domain architecture among exchangeable apolipoproteins with potential functional implications.
    Pearson K; Saito H; Woods SC; Lund-Katz S; Tso P; Phillips MC; Davidson WS
    Biochemistry; 2004 Aug; 43(33):10719-29. PubMed ID: 15311933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genome-wide association meta-analysis on apolipoprotein A-IV concentrations.
    Lamina C; Friedel S; Coassin S; Rueedi R; Yousri NA; Seppälä I; Gieger C; Schönherr S; Forer L; Erhart G; Kollerits B; Marques-Vidal P; Ried J; Waeber G; Bergmann S; Dähnhardt D; Stöckl A; Kiechl S; Raitakari OT; Kähönen M; Willeit J; Kedenko L; Paulweber B; Peters A; Meitinger T; Strauch K; ; Lehtimäki T; Hunt SC; Vollenweider P; Kronenberg F
    Hum Mol Genet; 2016 Aug; 25(16):3635-3646. PubMed ID: 27412012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum apolipoprotein A-I, A-II and B levels and their discriminative values in relatives of patients with coronary artery disease.
    Kukita H; Hiwada K; Kokubu T
    Atherosclerosis; 1984; 51(2-3):261-7. PubMed ID: 6430307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.